Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • Israeli pharma firm NeuroRX completes SPAC merger at $1.5 billion valuation
31 May

Israeli pharma firm NeuroRX completes SPAC merger at $1.5 billion valuation

By admin 0 Comments

NoCamels: Clinical-stage small molecule drugmaker announces merger with Big Rock Partners Acquisition Corporation to trade on Nasdaq exchange

Details
Vote up!
Vote down!

Points: 11

Category: 
Startup Israel
Israeli startups
Israeli high tech
special purpose acquisition companies SPAC
NeuroRX
biotechnology
Big Rock Partners Acquisition Corporation
  • Log in or register to post comments

Author

anon

admin

Hot

  • EQUIVALENCE? VP Vance Says Suffering of “Innocent Palestinians and Innocent Israeli Hostages” Is “Heartbreaking’
  • Mikie Sherrill Beats Crowded Field, Including Josh Gottheimer, To Become Democratic Candidate For NJ Governor
  • Mamdani Gains Surprising Hearing from Satmar Leader in NYC Mayoral Race

User login

  • Create new account
  • Request new password

Recent comments

No comments available.